Michael Severino, EVP, R&D and CSO at AbbVie Inc. (ABBV), sold 50,000 shares at $96.97 ($4.9M) on 2018-08-17, disclosed to the SEC on 2018-08-21.
Open-market sale of $4.9M ABBV by EVP, R&D and CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.97 | 20,800 | $2.0M | 41.4% |
| 2 | $97.91 | 29,200 | $2.9M | 58.6% |
| Total | $97.52 avg | 50,000 | $4.9M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-10 | $90.7M | — | Filing → |
| ABBV | SELL | 2020-11-06 | $17.0M | — | Filing → |
| ABBV | SELL | 2018-03-02 | $623K | — | Filing → |